1. Home
  2. NRXP vs NVNI Comparison

NRXP vs NVNI Comparison

Compare NRXP & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • NVNI
  • Stock Information
  • Founded
  • NRXP 2015
  • NVNI 2019
  • Country
  • NRXP United States
  • NVNI Brazil
  • Employees
  • NRXP N/A
  • NVNI N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • NVNI
  • Sector
  • NRXP Health Care
  • NVNI
  • Exchange
  • NRXP Nasdaq
  • NVNI Nasdaq
  • Market Cap
  • NRXP 32.6M
  • NVNI 31.5M
  • IPO Year
  • NRXP N/A
  • NVNI N/A
  • Fundamental
  • Price
  • NRXP $3.02
  • NVNI $0.37
  • Analyst Decision
  • NRXP Strong Buy
  • NVNI
  • Analyst Count
  • NRXP 4
  • NVNI 0
  • Target Price
  • NRXP $28.50
  • NVNI N/A
  • AVG Volume (30 Days)
  • NRXP 187.5K
  • NVNI 1.3M
  • Earning Date
  • NRXP 08-13-2025
  • NVNI 08-07-2025
  • Dividend Yield
  • NRXP N/A
  • NVNI N/A
  • EPS Growth
  • NRXP N/A
  • NVNI N/A
  • EPS
  • NRXP N/A
  • NVNI N/A
  • Revenue
  • NRXP N/A
  • NVNI $31,250,627.00
  • Revenue This Year
  • NRXP N/A
  • NVNI $12.05
  • Revenue Next Year
  • NRXP N/A
  • NVNI $15.02
  • P/E Ratio
  • NRXP N/A
  • NVNI N/A
  • Revenue Growth
  • NRXP N/A
  • NVNI 1491.58
  • 52 Week Low
  • NRXP $1.10
  • NVNI $0.14
  • 52 Week High
  • NRXP $6.01
  • NVNI $12.19
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 43.71
  • NVNI 59.97
  • Support Level
  • NRXP $2.89
  • NVNI $0.33
  • Resistance Level
  • NRXP $3.53
  • NVNI $0.44
  • Average True Range (ATR)
  • NRXP 0.15
  • NVNI 0.04
  • MACD
  • NRXP -0.06
  • NVNI 0.01
  • Stochastic Oscillator
  • NRXP 18.97
  • NVNI 70.51

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

Share on Social Networks: